首页> 外文期刊>Health policy >Effects of EU harmonization policies on national public supervision of clinical trials: A dynamic cycle of institutional change and institutional work
【24h】

Effects of EU harmonization policies on national public supervision of clinical trials: A dynamic cycle of institutional change and institutional work

机译:欧盟协调政策对临床试验国家公共监督的影响:体制变革与机构工作的动态周期

获取原文
获取原文并翻译 | 示例
       

摘要

Background: The EU Clinical Trials Directive (EUCTD) and the EU Clinical Trials Regulation aim to harmonize good clinical practice (GCP) of clinical trials across Member States. Using the Netherlands as a case study, this paper analyzes how endeavours to implement the EUCTD set in motion a dynamic process of institutional change and institutional work. This process lead to substantial differences between policy and actual practice; therefore, it is important to learn more about the implementation of harmonization policies.
机译:背景:欧盟临床试验指令(视科)和欧盟临床试验法规旨在协调跨会员国的临床实践(GCP)临床试验。 本文使用荷兰作为案例研究,分析了实施主动案中的机构变革和体制工作的动态过程中的努力。 该过程导致政策和实践之间的实质性差异; 因此,重要的是要了解更多有关协调政策的实施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号